A case report highlights a 51-year-old man with stage IV non-small cell lung cancer and brain metastasis who received whole ...
In the last decade, immunotherapy agents changed the treatment landscape for Non-Small Cell Lung Cancer (NSCLC)."BUFFALO, NY ...
BioNTech (NASDAQ:BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed ...
Grade 3-5 adverse events were comparable between both treatment groups. Evidence Rating Level: 1 (Excellent) Study Rundown: ...
The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing ...
The following is a summary of “Association of mutation profiles with metastasis in patients with non-small cell lung cancer,” ...
The FDA approved a wearable tumor-treating fields (TTFields) device (Optune Lua) for concurrent use with a PD-1/PD-L1 ...
In another positive development for the lung cancer community, NICE has also given its blessing to NHS use of MSD's $25 ...
First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for more than 80% of lung cancer cases. The treatment plan and goal of treatment depend on the stage of your ...
Verywell Health on MSN1y
How Non-Small Cell Lung Cancer Is TreatedEarly-stage cancers may be treated with surgery or a specialized form of radiation therapy if surgery is not possible.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback